Issue 1/2018
Content (9 Articles)
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity
Alberto Verrotti, Romina Moavero, Gianvito Panzarino, Claudia Di Paolantonio, Renata Rizzo, Paolo Curatolo
A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe
Josiah T. Masuka, Precious Chipangura, Priscilla P. Nyambayo, Andy Stergachis, Star Khoza
Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus
Noboru Kurinami, Seigo Sugiyama, Hiroyuki Nishimura, Ayami Morita, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouchi, Tomio Jinnouchi, Hideaki Jinnouchi
Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study
Akiko Mizukami, Keiko Sato, Koichi Adachi, Sean Matthews, Katsiaryna Holl, Taizo Matsuki, Toshihiko Kaise, Desmond Curran
Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction
Mikie Yamato, Kyoichi Wada, Tomohiro Hayashi, Mai Fujimoto, Kouichi Hosomi, Akira Oita, Mitsutaka Takada
Improvements in Quality-Adjusted Life Years and Cost–Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study
Eiichiro Kamagata, Kazuo Yamada
Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects
Maulik R. Patel, Kevinkumar A. Kansagra, Devang P. Parikh, Deven V. Parmar, Hardik B. Patel, Mayur M. Soni, Uday S. Patil, Harilal V. Patel, Jaimik A. Patel, Swagat S. Gujarathi, Krupi V. Parmar, Nuggehally R. Srinivas
Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece
Charalampos Tzanetakos, Alexandra Bargiota, Georgia Kourlaba, George Gourzoulidis, Nikos Maniadakis
Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China
Na Li, Bin Zheng, Hong-Fu Cai, Jing Yang, Xiao-Feng Luo, Li-Zhu Weng, Feng-Mei Zhan, Mao-Bai Liu